The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,287,851 in first-year total cost, median $798,536.
Most frequent study sections
- Immunity and Host Defense Study Section[IHD]1
- Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section[IRAP]1
- Special Emphasis Panel[ZRG1 IDIB-E (90)]1
Most frequent institutions
- UNIVERSITY OF ALABAMA AT BIRMINGHAM1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
- UNIVERSITY OF MARYLAND BALTIMORE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis1R01AI167629-01A1 | BROTMAN, REBECCA M.RAVEL, JACQUES | UNIVERSITY OF MARYLAND BALTIMORE, MD | $798,536 | ZRG1 |
| 2020 | Natural History of C. trachomatis urogenital and rectal infections1R01AI151075-01 | DEAN, DEBORAH ANNEREAD, TIMOTHY D. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $816,577 | IRAP |
| 2020 | Host Immune Responses to Chlamydia trachomatis Candidate Vaccine Antigens and their Association with Clinical Correlates of Protective Immunity in Women1R01AI148359-01A1 | GEISLER, WILLIAM M | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $672,738 | IHD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.